CNS/Neurology market research reports by DelveInsight

• Neurological Diagnostic and Monitoring Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Aug 01, 2023  |  Published by: DelveInsight  |  USD 4,250

  Neurological Diagnostic and Monitoring Equipment - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Neurological Diagnostic and Monitoring Equipment Market By Type (Invasive and Non-Invasive), Product Type (Magneto-Encephalography Devices (Meg), Electroencephalography Device ... Read More

• Obsessive-Compulsive Disorder - Epidemiology Forecast - 2032

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 3,950

  Obsessive-Compulsive Disorder - Epidemiology Forecast - 2032 Key Highlights Obsessive-compulsive disorder (OCD) has been given increased attention in DSM-5, receiving its chapter. However, the diagnostic criteria for OCD in DSM-5 remain largely the same as in DSM-IV, requiring either obsessions or c ... Read More

• Schizoaffective Disorder - Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 1,250

  Schizoaffective Disorder - Pipeline Insight, 2023 DelveInsight’s, “Schizoaffective Disorder - Pipeline Insight, 2023” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Schizoaffective disorder pipeline landscape. It covers the pipeline drug profiles, including clini ... Read More

• Glioblastoma- Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 5,000

  Glioblastoma- Pipeline Insight, 2023 DelveInsight’s, “Glioblastoma- Pipeline Insight, 2023” report provides comprehensive insights about 190+ companies and 200+ pipeline drugs in Glioblastoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. ... Read More

• Fibromyalgia- Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Fibromyalgia- Pipeline Insight, 2023 DelveInsight’s, “Fibromyalgia- Pipeline Insight, 2023” report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Fibromyalgia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. I ... Read More

• Obsessive-Compulsive Disorder - Market Insight, Epidemiology And Market Forecast - 2032

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Obsessive-Compulsive Disorder - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights Obsessive-compulsive disorder (OCD) has been given increased attention in DSM-5, receiving its chapter. However, the diagnostic criteria for OCD in DSM-5 remain largely the same as in DSM-IV, requi ... Read More

• Brain metastases- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 2,500

  Brain metastases- Pipeline Insight, 2023 DelveInsight’s, “Brain metastases- Pipeline Insight, 2023” report provides comprehensive insights about 40+ companies and 45+ pipeline drugs in Brain metastases pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage ... Read More

• Attention-deficit/hyperactivity disorder (ADHD) - Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 2,000

  Attention-deficit/hyperactivity disorder (ADHD) - Pipeline Insight, 2023 DelveInsight’s, “Attention Deficit Hyperactivity Disorder- Pipeline Insight, 2023” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Attention Deficit Hyperactivity Disorder pipeline landscape ... Read More

• Autistic Disorder- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 2,000

  Autistic Disorder- Pipeline Insight, 2023 DelveInsight’s, “Autistic Disorder- Pipeline Insight, 2023” report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Autistic Disorder pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical st ... Read More

• Neuroendocrine Tumors- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 2,500

  Neuroendocrine Tumors- Pipeline Insight, 2023 DelveInsight’s, “Neuroendocrine Tumors- Pipeline Insight, 2023,” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Neuroendocrine Tumors pipeline landscape. It covers the pipeline drug profiles, including clinical and n ... Read More

• Amyotrophic Lateral Sclerosis- Pipeline Insight, 2023

  May 01, 2023  |  Published by: DelveInsight  |  USD 3,000

  Amyotrophic Lateral Sclerosis- Pipeline Insight, 2023 DelveInsight’s, “Amyotrophic Lateral Sclerosis- Pipeline Insight, 2023” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It covers the pipeline drug profiles, ... Read More

• Glioma - Epidemiology Forecast - 2032

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,950

  Glioma - Epidemiology Forecast - 2032 Key Highlights Gliomas are extremely diffuse, infiltrative tumors that impact the surrounding brain tissue. According to the American Association of Neurological Surgeons (AANS), gliomas constitute 78% of malignant brain tumors in adults, making them the most co ... Read More

• Glioma - Competitive Landscape, 2023

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  Glioma - Competitive Landscape, 2023 DelveInsight’s, “Glioma - Competitive landscape, 2023,” report provides comprehensive insights about 200+ companies and 220+ drugs in Glioma Competitive landscape. It covers the therapeutics assessment by product type, stage, route of administration, and molecul ... Read More

• Neurology Devices- Market Insights, Competitive Landscape, and Market Forecast - 2027

  Dec 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Neurology Devices- Market Insights, Competitive Landscape, and Market Forecast - 2027 Neurology Devices Market By Device Type (Neurostimulation Devices, Neurosurgery Devices, Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, And Others ], By Application (Diagnosis And Treatm ... Read More

• Chronic Smell and Flavor Loss – Epidemiology Forecast—2032

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  Chronic Smell and Flavor Loss – Epidemiology Forecast—2032 DelveInsight’s ‘Chronic smell and flavor loss – Epidemiology Forecast—2032’ report delivers an in-depth understanding of Chronic smell and flavor loss historical and forecasted epidemiology in the United States, the EU5 (Germany, Spain, Ital ... Read More

• Amyotrophic Lateral Sclerosis - Epidemiology Forecast - 2032

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 4,750

  Amyotrophic Lateral Sclerosis - Epidemiology Forecast - 2032 DelveInsight's ‘Amyotrophic Lateral Sclerosis - Epidemiology Forecast–2032’ report delivers an in-depth understanding of the disease, historical and forecasted Amyotrophic Lateral Sclerosis epidemiology in the United States, EU-4 (Germany, ... Read More

• Glioblastoma Multiforme (GBM) Market Insight, Epidemiology and Market Forecast -2032

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 9,500

  Glioblastoma Multiforme (GBM) Market Insight, Epidemiology and Market Forecast -2032 DelveInsight's "" Glioblastoma Multiforme Market - Market Insights, Epidemiology and Market Forecast– 2032” report delivers an in-depth understanding of the GBM, historical and forecasted epidemiology as well as the ... Read More

• Glioblastoma Multiforme (GBM) - Epidemiology Forecast - 2032

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 4,750

  Glioblastoma Multiforme (GBM) - Epidemiology Forecast - 2032 DelveInsight's "" Glioblastoma Multiforme - Epidemiology Forecast– 2032” report delivers an in-depth understanding of the GBM, historical and forecasted epidemiology trends in the United States, the EU-4 (Germany, Spain, Italy, France), th ... Read More

• Amyotrophic Lateral Sclerosis - Market Insight, Epidemiology And Market Forecast - 2032

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 9,500

  Amyotrophic Lateral Sclerosis - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight's ”Amyotrophic Lateral Sclerosis- Market Insights, Epidemiology, and Market Forecast-2032"" report delivers an in-depth understanding of the ALS, historical and forecasted epidemiology as well as the ... Read More

• Traumatic Brain Injury (TBI) Assessment Devices - Market Insights, Competitive Landscape and Market Forecast-2027

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Traumatic Brain Injury (TBI) Assessment Devices - Market Insights, Competitive Landscape and Market Forecast-2027 Traumatic Brain Injury (TBI) Assessment Devices Market By Device Type (Imaging Devices And Monitoring Devices), By Technology (Intracranial Pressure (ICP) Monitoring And Partial Pressure ... Read More

• Frontotemporal Dementia - Market Insight, Epidemiology And Market Forecast - 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Frontotemporal Dementia - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Frontotemporal Dementia-Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Frontotemporal dementia (FTD), historical and forecasted epidemiology as ... Read More

• Alcohol Use Disorder (AUD) - Market Insight, Epidemiology And Market Forecast - 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Alcohol Use Disorder (AUD) - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Alcohol Use Disorder - Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Alcohol Use Disorder, historical and forecasted epidemiology as well as ... Read More

• EXSERVAN Drug Insight and Market Forecast – 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  EXSERVAN Drug Insight and Market Forecast – 2032 “EXSERVAN Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EXSERVAN for Amyotrophic Lateral Sclerosis in seven major markets. A detailed picture of the EXSERVAN for Amyotrophic Lateral Sclerosis in 7MM, i.e., Unite ... Read More

• VRAYLAR Emerging Drug Insight and Market Forecast – 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 3,250

  VRAYLAR Emerging Drug Insight and Market Forecast – 2032 “VRAYLAR, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VRAYLAR for Treatment Resistant Depression in seven major markets. A detailed picture of the VRAYLAR for Treatment Resistant Depression in ... Read More

• VRAYLAR, Emerging Drug Insight and Market Forecast – 2032

  Aug 01, 2022  |  Published by: DelveInsight  |  USD 3,250

  VRAYLAR, Emerging Drug Insight and Market Forecast – 2032 “VRAYLAR, Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VRAYLAR for Treatment Resistant Depression in seven major markets. A detailed picture of the VRAYLAR for Treatment Resistant Depression i ... Read More

< prev 1 2 3 4 5 6 7 8 next >